Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Practical Synthesis of 7-Bromo-4-chloro-1H-indazol-3-amine: An Important Intermediate to Lenacapavir
Molecules ( IF 4.2 ) Pub Date : 2024-06-07 , DOI: 10.3390/molecules29122705 Naeem Asad 1 , Michael Lyons 1 , Shirley Muniz Machado Rodrigues 1 , Justina M Burns 1 , Thomas D Roper 1 , G Michael Laidlaw 1 , Saeed Ahmad 1 , B Frank Gupton 1 , Douglas Klumpp 1 , Limei Jin 1
Molecules ( IF 4.2 ) Pub Date : 2024-06-07 , DOI: 10.3390/molecules29122705 Naeem Asad 1 , Michael Lyons 1 , Shirley Muniz Machado Rodrigues 1 , Justina M Burns 1 , Thomas D Roper 1 , G Michael Laidlaw 1 , Saeed Ahmad 1 , B Frank Gupton 1 , Douglas Klumpp 1 , Limei Jin 1
Affiliation
7-Bromo-4-chloro-1H-indazol-3-amine is a heterocyclic fragment used in the synthesis of Lenacapavir, a potent capsid inhibitor for the treatment of HIV-1 infections. In this manuscript, we describe a new approach to synthesizing 7-bromo-4-chloro-1H-indazol-3-amine from inexpensive 2,6-dichlorobenzonitrile. This synthetic method utilizes a two-step sequence including regioselective bromination and heterocycle formation with hydrazine to give the desired product in an overall isolated yield of 38–45%. The new protocol has been successfully demonstrated on hundred-gram scales without the need for column chromatography purification. This new synthesis provides a potential economical route to the large-scale production of this heterocyclic fragment of Lenacapavir.
中文翻译:
7-溴-4-氯-1H-吲唑-3-胺的实际合成:来那卡韦的重要中间体
7-Bromo-4-氯-1H-indazol-3-amine 是一种杂环片段,用于合成 Lenacapavir,Lenacapavir 是一种有效的衣壳抑制剂,用于治疗 HIV-1 感染。在这篇手稿中,我们描述了一种从廉价的 2,6-二氯苯甲腈合成 7-溴-4-氯-1H-吲唑-3-胺的新方法。该合成方法采用两步序列,包括区域选择性溴化和与肼形成杂环,以 38-45% 的总分离产率得到所需产物。新方案已在百克规模上成功论证,无需柱层析纯化。这种新的合成方法为大规模生产 Lenacapavir 杂环片段提供了一条潜在的经济途径。
更新日期:2024-06-07
中文翻译:
7-溴-4-氯-1H-吲唑-3-胺的实际合成:来那卡韦的重要中间体
7-Bromo-4-氯-1H-indazol-3-amine 是一种杂环片段,用于合成 Lenacapavir,Lenacapavir 是一种有效的衣壳抑制剂,用于治疗 HIV-1 感染。在这篇手稿中,我们描述了一种从廉价的 2,6-二氯苯甲腈合成 7-溴-4-氯-1H-吲唑-3-胺的新方法。该合成方法采用两步序列,包括区域选择性溴化和与肼形成杂环,以 38-45% 的总分离产率得到所需产物。新方案已在百克规模上成功论证,无需柱层析纯化。这种新的合成方法为大规模生产 Lenacapavir 杂环片段提供了一条潜在的经济途径。